FibroGen (FGEN) Misses Q1 EPS by 26c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.78), $0.26 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $34 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• 1-800-FLOWERS.Com (FLWS) Misses Q4 EPS by 10c, Misses on Revenue; Offers Guidance
• Designer Brands Inc. (DBI) Tops Q2 EPS by 8c, Misses on Revenue; Offers FY27 EPS Guidance